3004 studies found for:    "Antifungal Agents"
Show Display Options
Rank Status Study
1 Active, not recruiting Short and Long-term Safety of Micafungin and Other Parenteral Antifungal Agents
Condition: Systemic Fungal Infections
Interventions: Drug: Parenteral micafungin application;   Drug: Other parenteral antifungal drugs
2 Completed Hygienic Socks With Antifungal Agent-loaded Microcapsules for Patients With Tinea Pedis
Condition: Tinea Pedis
Interventions: Drug: Anti-fungal agent (Clotrimazole) loaded microcapsules;   Drug: Placebo
3 Completed Antifungal Use in Oncohematological Neutropenic Patients
Condition: Invader Fungal Infection
Intervention: Drug: Antifungal drug. VORICONAZOL. (VFEND®)
4 Unknown  Antifungal Locks to Treat Fungal-Related Central Line Infections
Condition: Central Line Fungal Infections
Intervention: Drug: amphotericin B liposomal (Ambisome)
5 Unknown  Efficacy and Safety of RV4104A Ointment in Onychomycosis
Condition: Onychomycosis
Intervention: Drug: Keratolytic/Antifungal
6 Terminated Validation of an Index of Neutropenia (D-index) in Febrile Neutropenic Cancer Patients
Conditions: Invasive Fungal Infections;   Invasive Aspergillosis;   Invasive Fusariosis
Intervention: Drug: caspofungin as preemptive antifungal therapy
7 Terminated Candida in the Respiratory Tract Secretions of Critically Ill Patients and The Efficacy of Antifungal Treatment
Conditions: Ventilator Associated Pneumonia;   Respiratory Tract Infection
Interventions: Other: Normal Saline;   Drug: anidulafungin
8 Recruiting International Pediatric Fungal Network
Condition: Pediatric Invasive Candidiasis
Intervention: Drug: Observational antifungal therapy
9 Completed Seifem Surveillance of Antifungal Combination Therapy In Hematologic Italian Centers
Condition: Fungal Infection
Intervention:
10 Unknown  Efficacy, Safety and Cost-effectiveness of a Sequential Therapy With RV4104A Ointment, Ciclopiroxolamine Cream and Ciclopirox Film-forming Solution Compared With Amorolfine Nail Lacquer in Dermatophytic Onychomycosis
Condition: Onychomycosis
Interventions: Drug: Amorolfine (Antifungal);   Drug: RV4104A, Ciclopiroxolamine, Cyclopirox (Keratolytic Agents/Antifungal)
11 Recruiting Empirical Versus Preemptive Antifungal Therapy
Conditions: Fungal Infection;   Leukemia;   Myelodysplastic Syndromes
Intervention: Drug: caspofungin acetate
12 Recruiting A Pharmacokinetic Study of Pediatric Micafungin Prophylaxis
Conditions: Immunocompromised;   Bone Marrow Transplant;   Cancer
Intervention: Drug: Micafungin
13 Terminated Comparison of 2 Antifungal Treatment (Empirical Versus Pre-Empirical) Strategies in Prolonged Neutropenia
Conditions: Malignant Hemopathy;   Duration of Neutropenia Following Chemotherapy > 10 Days
Intervention: Drug: Amphotericin B
14 Completed
Has Results
β-D-Glucan (BDG) Surveillance With Preemptive Anidulafungin vs. Standard Care for Invasive Candidiasis in Surgical Intensive Care Unit (SICU) Patients
Condition: Invasive Candidiasis
Interventions: Drug: Preemptive Therapy with Anidulafungin;   Drug: Empiric antifungal therapy based on physician discretion.
15 Terminated Comparative Study of Micafungin (FK463) Versus Placebo as Prophylactic Antifungal Therapy in the ICU
Condition: Invasive Fungal Infections
Interventions: Drug: Micafungin;   Drug: Placebo
16 Not yet recruiting Laser Treatment for Onychomycosis in Diabetes
Conditions: Diabetes Mellitus, Type 2;   Onychomycosis
Interventions: Device: Laser Treatment YAG laser;   Drug: Standard Treatment (control group) terbinafine HCl
17 Completed PROPHYSOME: Pilot Study on Safety of a Weekly Administration of 10mg/kg of AmBisome® in Antifungal Prophylaxis Treatment of Allogeneic Stem-Cell Transplantation and Acute Leukaemia
Condition: Leukemia
Intervention: Drug: Ambisome
18 Completed PROPHESSOR: AmBisome in Antifungal Primary Prophylaxis Treatment of High Risk Patients Undergoing Allogeneic Stem Cell Transplantation
Condition: Fungus Diseases
Intervention: Drug: AmBisome
19 Completed Withdrawal of Antifungal Treatment for Histoplasmosis in Patients After Improved Immune Response to Anti-HIV Drugs
Conditions: HIV Infections;   Histoplasmosis
Intervention:
20 Completed Safety and Antifungal Activity of Recombinant Interferon-Gamma 1b (rIFN-Gamma 1b) Given With Standard Therapy in Patients With Cryptococcal Meningitis
Conditions: Meningitis, Cryptococcal;   HIV Infections
Interventions: Drug: Itraconazole;   Drug: Flucytosine;   Drug: Fluconazole;   Drug: Amphotericin B;   Drug: Interferon gamma-1b

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years